232 related articles for article (PubMed ID: 7055792)
21. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
Gillespie GY; Hansen CB; Hoskins RG; Russell SW
J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
[TBL] [Abstract][Full Text] [Related]
22. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
Ting CC; Rodgigues D; Bushar GS; Herberman RB
J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
[TBL] [Abstract][Full Text] [Related]
23. T and B lymphocyte migration into syngeneic tumors.
Elboim CM; Reinisch CL; Schlossman SF
J Immunol; 1977 Mar; 118(3):1042-8. PubMed ID: 300384
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated immune response to Shope fibroma virus-induced tumors in adult rabbits.
Scott CB; Holdbrook R; Sell S
J Natl Cancer Inst; 1981 Apr; 66(4):681-9. PubMed ID: 7014966
[TBL] [Abstract][Full Text] [Related]
25. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
26. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
27. [Humoral reactions in BALC/c mice with sarcomatous Moloney-induced tumor].
Yakimenko LV; Vetrova EP; Kaminskaya LP; Berdova AG; Umansky YA
Vopr Onkol; 1979; 25(9):46-50. PubMed ID: 573520
[TBL] [Abstract][Full Text] [Related]
28. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
Takeichi N; Austin FC; Oikawa T; Boone CW
Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
[TBL] [Abstract][Full Text] [Related]
29. Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
Zaleskis G; Ho RL; Diegelman P; Maccubbin D; Ujházy P; Mihich E; Ehrke MJ
Oncol Res; 1994; 6(4-5):183-94. PubMed ID: 7841541
[TBL] [Abstract][Full Text] [Related]
30. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
31. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
Przepiorka D; Mokyr MB; Dray S
Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
[TBL] [Abstract][Full Text] [Related]
33. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
Fredrickson GG; Bennett M
Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
[TBL] [Abstract][Full Text] [Related]
35. Identification and cytotoxic reactivity of inflammatory cells recovered from progressing or regressing syngeneic UV-induced murine tumors.
Lill PH; Fortner GW
J Immunol; 1978 Nov; 121(5):1854-60. PubMed ID: 309483
[TBL] [Abstract][Full Text] [Related]
36. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
37. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
Lukacher AE; Moser JM; Hadley A; Altman JD
J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
[TBL] [Abstract][Full Text] [Related]
38. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
39. Chemical enhancement of tumor immunogenicity.
Eggers AE; Hibbard CA; Civin CI; Wunderlich JR
J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
[TBL] [Abstract][Full Text] [Related]
40. Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity.
Do JS; Choi YH; Shin SH; Yi HK; Hwang PH; Nam SY
Immunol Lett; 2004 Aug; 95(1):77-84. PubMed ID: 15325801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]